152 related articles for article (PubMed ID: 3197992)
1. Screening of colorectal tumours using an improved faecal occult blood test. Quantitative aspects.
Häkkinen I; Paasivuo R; Partanen P
Gut; 1988 Sep; 29(9):1194-7. PubMed ID: 3197992
[TBL] [Abstract][Full Text] [Related]
2. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
Brenner H; Tao S
Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
[TBL] [Abstract][Full Text] [Related]
3. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and comparison of an immunochemical and a guaiac faecal occult blood screening test for colorectal neoplasia.
Rozen P; Knaani J; Papo N
Eur J Cancer Prev; 1995 Dec; 4(6):475-81. PubMed ID: 8580783
[TBL] [Abstract][Full Text] [Related]
5. Finding colorectal tumours with an immunological faecal occult blood test in symptomatic primary health care patients.
Kemppainen M; Häkkinen I; Räihä I; Pomoell R; Sourander L
Age Ageing; 1994 Sep; 23(5):365-70. PubMed ID: 7825480
[TBL] [Abstract][Full Text] [Related]
6. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
8. Intervention in large bowel carcinogenesis--does screening improve prognosis?
Farrands PA; Britton DC
Scand J Gastroenterol Suppl; 1984; 104():151-9. PubMed ID: 6597547
[TBL] [Abstract][Full Text] [Related]
9. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
[TBL] [Abstract][Full Text] [Related]
10. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
[TBL] [Abstract][Full Text] [Related]
11. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the new immunological test Hemoblot for detecting occult blood in faeces.
Jeanson A; Jamart J; Maisin JM; Vanheuverzwyn R; Gohy P; Debongnie JC; Rentier B
Eur J Cancer Prev; 1994 Sep; 3(5):407-12. PubMed ID: 8000309
[TBL] [Abstract][Full Text] [Related]
13. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 1: Positive predictive value of occult blood testing].
Schellenberger U; Raabe A; Erler K
Z Arztl Fortbild (Jena); 1987; 81(19):1007-9. PubMed ID: 3439213
[No Abstract] [Full Text] [Related]
14. [A double immunochemical method for detecting faecal haemoglobin and albumin in rectal screening].
Tarpay A; Szabadosné Németh M; Orosz E; Kásler M; Burai M; Pap A; Ottó S
Magy Onkol; 2011 Nov; 55(4):268-73. PubMed ID: 22128309
[TBL] [Abstract][Full Text] [Related]
15. Risks and benefits of mass screening for colorectal neoplasia with the stool guaiac test.
Winchester DP; Sylvester J; Maher ML
CA Cancer J Clin; 1983; 33(6):333-43. PubMed ID: 6416636
[No Abstract] [Full Text] [Related]
16. Inappropriate and improper use of fecal occult blood tests for colorectal cancer screening in the VA Medical System.
Ahmed F; Murthy UK
Am J Gastroenterol; 2006 Jun; 101(6):1401. PubMed ID: 16771975
[No Abstract] [Full Text] [Related]
17. [A study on the complementary scheme of mass screening for colorectal cancer in an asymptomatic population].
Zhou DY; Feng FC; Zhang YL
Zhonghua Nei Ke Za Zhi; 1994 Jun; 33(6):367-9. PubMed ID: 7867422
[TBL] [Abstract][Full Text] [Related]
18. Screening for colorectal neoplasms with a new immunological human faecal haemoglobin and albumin test.
Sieg A; Hertel A; John MR; Lüthgens K; Schmidt-Gayk H
Eur J Cancer Prev; 1998 Aug; 7(4):279-85. PubMed ID: 9806116
[TBL] [Abstract][Full Text] [Related]
19. Screening for colorectal carcinoma: an analysis of the sensitivity of haemoccult.
Thomas WM; Pye G; Hardcastle JD; Walker AR
Br J Surg; 1992 Aug; 79(8):833-5. PubMed ID: 1393487
[TBL] [Abstract][Full Text] [Related]
20. How to perform the fecal occult blood test.
Gnauck R; Macrae FA; Fleisher M
CA Cancer J Clin; 1984; 34(3):134-47. PubMed ID: 6426710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
